Copyright
©The Author(s) 2024.
World J Radiol. Jun 28, 2024; 16(6): 168-183
Published online Jun 28, 2024. doi: 10.4329/wjr.v16.i6.168
Published online Jun 28, 2024. doi: 10.4329/wjr.v16.i6.168
Table 1 Clinical pearls for contrast-induced acute kidney injury in every day clinical practice
Risk factors-complications |
Serum creatinine elevation occurs within 48-72 hours after the injection of the CM, with the first 24 hours post-exposure are crucial to the development of CI-AKI |
Patients with preexisting CKD, elderly, and renal transplant recipients are at increased risk for CI-AKI development |
Renal function via serum creatinine and eGFR calculation should be evaluated in high-risk patients before exposure to CM for CI-AKI risk assessment |
Other notable complications of CM exposure: Myocardial infarction, shock, stroke, death, longer in-hospital stays |
Prevention |
CM considerations: Apply non-ionic, hypo-osmolar CM at lowest dose, prewarm at 37 °C |
Discontinue nephrotoxic drugs: Non-steroidal anti-inflammatory drugs, aminoglycosides, metformin |
Periprocedural hydration with normal saline in patients at risk: |
Three mL/kg/hour 1 hour before to 4 hours after the procedure |
One mL/kg/hour 12 hours before to 12 hours after the procedure |
Individualized use of specialized systems (RenalGuard/DyeVert) in coronary procedures |
- Citation: Theofilis P, Kalaitzidis R. Navigating nephrotoxic waters: A comprehensive overview of contrast-induced acute kidney injury prevention. World J Radiol 2024; 16(6): 168-183
- URL: https://www.wjgnet.com/1949-8470/full/v16/i6/168.htm
- DOI: https://dx.doi.org/10.4329/wjr.v16.i6.168